Vivos Therapeutics (VVOS) stock gains as company receives FDA clearance for its DNA appliance to treat obstructive sleep ...

Vivos Therapeutics (NASDAQ: VVOS) , a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep related ...

The gross proceeds to the Company from the offering are expected to be approximately $4.3 million, before deducting the placement agent's fees and other offering expenses payable by the Company. The ...

Vivos Therapeutics (NASDAQ: VVOS), a leading medical-device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep-related ...

Vivos Therapeutics Inc (NASDAQ:VVOS) shares are trading lower by 26.1% to $3.05 during Thursday’s session after the company ...

On Wednesday, the FDA granted 510(k) clearance to Vivos Therapeutics, Inc.’s (NASDAQ:VVOS) flagship oral medical device, ...

Vivos Therapeutics, Inc. (VVOS), a medical device and technology company, announced on Thursday that it has inked a deal with ...

Short interest in Vivos Therapeutics Inc (NASDAQ:VVOS) decreased during the last reporting period, falling from 58.82K to 56.53K. This put 2.28% of the company's publicly available shares short.

Vivos is poised to disrupt the very significant pediatric obstructive sleep apnea (OSA) market with new FDA clearance and new strategic marketing ...

Real-time index price for Nasdaq Composite (NASX), along with buy or sell indicators, analysis, charts, historical ...

What a session it was for a certain Colorado-based %Healthcare company after it was announced that it received the US Food ...

(RTTNews) - Vivos Therapeutics, Inc. (VVOS) announced on Wednesday that it has obtained ... In pre-market activity on the Nasdaq, the shares are trading at $3.19, up 17.50%. Vivos Therapeutics ...